The story of Viagra and its effect on the pharmaceutical landscape presents a thorny question for investors . Initially a hugely successful drug, copycat medications have significantly chipped away at its https://matteoldcg001398.slypage.com/42252665/the-blue-pill-and-pharma-a-risky-investment